https://pubs.rsc.org/en/Content/ArticleLanding/2024/FO/D4FO03543G
Cardamonin protects against diabetic cardiomyopathy by activating macrophage NRF2 signaling through...
Diabetic cardiomyopathy (DCM) contributes to a large proportion of heart failure incidents in the diabetic population, but effective therapeutic approaches are...
protectsdiabeticcardiomyopathy